chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I feel short of breath; feel tired; headaches; body ache; I've been hot and cold; Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (I've been hot and cold), COUGH (Dry cough), DYSPNOEA (I feel short of breath), MYALGIA (body ache) and FATIGUE (feel tired) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anxiety, Depression, Migraine and Sleep disorder.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (I've been hot and cold), COUGH (Dry cough), MYALGIA (body ache) and HEADACHE (headaches). On 26-Aug-2021, the patient experienced DYSPNOEA (I feel short of breath) and FATIGUE (feel tired). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (I've been hot and cold), COUGH (Dry cough), DYSPNOEA (I feel short of breath), MYALGIA (body ache), FATIGUE (feel tired) and HEADACHE (headaches) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment medication was reported by patient.  Patient reported concomitant medication for anxiety, depression, migraines and sleep.  Patient reported no history of COVID-19 infection nor history of myocarditis and pericarditis.
tested positive; tested positive; I've had three (3) COVID shots (including booster); I've had three (3) COVID shots (including booster); This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 3 (booster), single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single and received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient reported on an unspecified date, event after 3 Covid shots, the patient tested positive for Covid. The patient underwent lab tests and procedures on an unspecified date which included sars-cov-2 test positive. The outcome of the events was unknown at the time of report.   The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Swollen Supraclavicular Lymph Node 24 hours after injection.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 19Apr2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included ulcerative colitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included nicotine (patches) (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EA8730) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 20Apr2021 at 14:00, the patient experienced swollen supraclavicular lymph node 24 hours after injection. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen supraclavicular lymph node was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Large raised lump (about 2 inches across) formed where injection was given. Became reddened and hot.  It was extremely painful. Redness went away but there is a deep lump there still and I experience severe shooting pains down the bone of my arm - sometimes enough to wake me in the night.  This is not a constant pain - it seems to be exacerbated by inactivity and also by cold but when it is hurting, the pain is significant.  Sometimes the pain is relieved by movement, heat, and also rubbing and sometimes it is not.   I also experienced severe muscle aches, chills, and low grade fever (100) for the first 48 hours after injection.  Not enough to go to the hospital but it was just as severe as my symptoms were when I had COVID 1 year prior to the vaccination.    I have also had considerable hair loss since the shot. There are no bald spots and this seems to be slowing down but my hair is significantly thinner since the shot. (I had had some hair loss after my first bout of COVID in August of 2020 and the vaccination seemed to exacerbate this again in Aug 2021 )
This case was reported by a pharmacist via call center representative and described the occurrence of jitteriness in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. In September 2018, less than a year after receiving SHINGRIX, the patient experienced jitteriness. On an unknown date, the outcome of the jitteriness was unknown. The reporter considered the jitteriness to be unrelated to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional stated that the patient received 1st dose of SHINGRIX 8 weeks ago from the reporting date. The patient received a steroid injection about a week ago from the reporting date. The patient experienced the expected jitteriness after receiving the steroid injection. The healthcare professional did not feel the jitteriness was related to SHINGRIX since it was expected with steroids. The healthcare professional did not wish to provide additional information since she felt jitteriness was related to steroid injection and not SHINGRIX.
Patient was only 11 at time of vaccination. Parent wrote "12" in age box on COVID-19 Vaccine Consent Form. No adverse events were reported.
Patient was given Moderna (0.5ml) as her second dose in the series, when she should have received Pfizer, as that was what she had received for her first dose.
I woke up, everything was fine, then I got up and I went deaf in my left ear. It felt like ear wax had run down onto my ear drum, but as it turns out it was worse than that and after 3 specialists treatments, no improvement.
Therapy non-responder. This case was reported by a healthcare professional and described an adult female subject who did not respond to immunization to hepatitis B vaccine recombinant (Engerix-B, GlaxoSmithKline) for prophylaxis.  On an unspecified date before 03 October 2006, the subject received 3rd dose of Engerix-B. On 03 October 2006, at an unspecified time after vaccination with Engerix-B, a hepatitis B surface antibody titer was negative.  Relevant tests results included [laboratory results/hospital investigations]. At the time of reporting the outcome of the event was was unspecified.
Case number PHEH2015US020306, is an initial spontaneous report from a nurse received on 08 Oct 2015. This report refers to a 28-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient received FLUVIRIN (batch number: 1515701) 0.5 ml intramuscular on 07 Oct 2015. It was reported that the patient received FLUVIRIN MDV that was out of temperature range at 47F before administration. No adverse event was reported.
Very large and hard knot, swelling, redness and hot to touch at the site of injection. No fever mom says.
Syncopal episode, dizziness, vomited, tingling to tongue, itching.
One week after receiving the vaccine, my left arm started to itch intensely. A large single hive formed. It was inflamed & felt hot to the touch. I called the pharmacy where I received it & was told that?s a common thing reported. To massage the area, use hydrocortisone cream for the itching, & let them know if it didn?t get better. I followed the directions & added Benadryl at bedtime. The next day on Thursday  the inflammation from the hive went down, but it remained bright red & felt hot to the touch. I used the cream & Benadryl that night. On Friday when I woke up the redness was nearly gone, but there was still discoloration and an added reddened area on my arm near the bend of my arm. It looked like a white ring was formed around the discolored hive area. Saturday it started to itch & got inflamed some more. A half circle shaped hive appeared around the original hive spot. I used hydrocortisone cream & took Benadryl at bedtime. This morning when I woke up it looked like a bullseye rash like from a tick bite! It has still been itchy some & others told me it feels warmer to the touch than the rest of my arm. I have taken pictures each day for documenting purposes that I can email you all. I called the pharmacist again today to let them know it had changed to look like the bullseye rash. I was asked if I have a penicillin allergy & I do not. My mother does. I asked what medications are related to PCN & the pharmacist named augmentin & amoxicillin-I?ve had both without issues. She said there is a very rare side effect being reported in folks with a PCN allergy. She said she was puzzled by the fact my reaction was late onset & suggested I report this. Also suggested to watch for fever, spreading rash, swelling of the tongue or throat, & to keep using the Benadryl for now. Was also advised to seek medical help if any of those symptoms arise.
Booster dose of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster dose of an expired vaccine) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 06-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster dose of an expired vaccine). On 06-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Booster dose of an expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment medication provided.
This spontaneous report was received from a registered nurse and refers to a 2 month old female patient. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 24-FEB-2017, the patient was vaccinated with one dose of LIQUID PEDVAXHIB injection (exact dose, route of administration, anatomical location, lot # and expiry date were not reported) and one dose of PENTACEL (formulation, exact dose, route of administration, anatomical location, lot # and expiry date were not provided) for prophylaxis. On 24-FEB-2017, unspecified time after receiving the two vaccinations, the patient was irritable, had decreased appetite and had a temperature of 99 Fahrenheit degrees. The patient received acetaminophen (TYLENOL) on an unspecified date in 2017, after the vaccination. The outcome of the events was reported was reported as recovering. The reporter did not provide the causality assessment between the events and LIQUID PEDVAXHIB. Additional information is not expected as there was no consent for further contact.
Moderna COVID-19 Vaccine EUA At 9:00 AM on January 22, itching, breaking out in hives on more than 50 % of the body. dizziness,  and passed out..  911 was called and I was taken by ambulance to hospital.  Given fluids, and the following medications,  Sodium Chloride 0.9%  1000ml by IV. methylprednisolone 125 mg by IVP, famotidine  20mg by IVP,  These were started at about 11:00 AM and by 3:pm I was release to go home feeling much better
I contracted COVID-19 on 05/25/2022 with symptoms of congestion, runny nose, cough, and fatigue. I was prescribed Paxlovid on 05/28/2022. I was ill for 5 days before my symptoms began to resolve. I am fully recovered with no lingering symptoms.
I missed my 2nd dose because I got COVID-19; I got COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got COVID-19) and PRODUCT DOSE OMISSION ISSUE (I missed my 2nd dose because I got COVID-19) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007821A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced COVID-19 (I got COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my 2nd dose because I got COVID-19). At the time of the report, COVID-19 (I got COVID-19) and PRODUCT DOSE OMISSION ISSUE (I missed my 2nd dose because I got COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
vomiting, diarrhea, >104, lethargic 4+ days;hospitalization w/IV fluids;
"25 cents" size area of erythema & induration at site 1 week after injection. No adenopathy or systemic symptoms (< at Varivax site). Possible secondary infection; soaks & erythromycin.
Shot given approx 1130 hrs 7 Jul 07. Illness (flu-like symptoms) at 24 hr mark. Soreness at injection site (left del.) on 9 July - "chest pain/tightness - with general achy all over body." 10 July, seen doctor about issues of past three days. Meds given - Atarax 10mg, PO/Piroxicam 10mg caps. Pleased on 24 hr quarters.
We identified that expired vaccine (LOT#047C21A) ? exp 11/7/21 had been administered to patients on 12/2/21.  Prior to administration, the vaccine had been stored at the recommended storage recommendations (freezer then fridge x 24 hours to thaw).  Vaccine vial was removed from freezer conditions on 12/1/21 prior to administration on 12/2/21.  No adverse events reported/identified.
Pt recvd 3 doses of Engerix-B & exp no medical problems or reactions; titer test result indicated no antibody conversion;
Patient inadvertently administered 1st dose of Moderna cov 19 vaccine to under age 18. Patient administered 2nd dose of Moderna cov 19 vaccine on 3/5/2021 after approval.
12/3/2020 08:00AM  body aches, fever 102.00 temperature, sore joints, weakness. Symptoms relieved next day.
A little under 48 hours after receiving second Moderna injection, I woke up with vertigo. I have never had vertigo before. The room was spinning horizontally and it would subside after sitting up for a short while. Once it subsided when I was sitting up, I laid down and the spinning began again. I got into the shower (dumb idea) and the spinning was no longer occurring, but I still felt off-balance and got a bit nauseous. It was at its worst for the hour after I woke up, but gradually has subsided since then. I did some vertigo relief maneuvers and they've helped, but I can tell I'm not 100% back to normal as of writing (11:54am). I would say I'm 90% back to normal. This could be a freak occurrence, but since I've never experienced vertigo before, I have a feeling the vaccine I received two days prior may have something to do with it.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. On 02-SEP-2015 the patient was vaccinated with an improperly stored dose of M-M-R II 0.5ml (rHA (recombinant human albumin), lot # J014876, expiration date 21-NOV-2015, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria of this vaccine was refrigerator/freezer (R/F) and type of excursion was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
My son started running a fever the night of 11/22. He had no other symptoms besides fever and lethargy. The evening of 11/23 he proceeded to have two seizures determined to be febrile caused. The first lasting 15 minutes and the second 3 hours later lasting 10 minutes. The ER doctor stated it was most likely caused by his fever which could have been caused by the MMR vaccine he received.
big fluid- filled blister 2 inches from site of injection.  Discoloration (darker) of skin around blister.
FEELING COLD; MILD FATIGUE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-MAR-2021, the subject experienced feeling cold. On 09-MAR-2021, the subject experienced mild fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the mild fatigue and feeling cold was not reported. This report was non-serious.
This spontaneous prospective pregnancy report as received from a Licensed Practical Nurse refers to a 17 year old female with none drug reactions/allergies. None pertinent medical history was reported. On 10-OCT-2014 the patient was vaccinated with VARIVAX, lot# reported as K002918, expiry date 26-FEB-2016, 0.5 ml, subcutaneous. The patient also received FLUMIST on the same day (10-OCT-2014), (dose and route not reported). The nurse reported that the patient who was pregnant received a dose of VARIVAX. She stated that at the time the VARIVAX was administered, it was not known that the patient was pregnant. She reported that the patient arrived to the clinic three days after receiving VARIVAX on 13-OCT-2014 and asked to have a pregnancy test done which resulted positive. At time of reporting (15-OCT-2014), the patient had 4 weeks and 5 days pregnancy. The LMP (Last Menstrual Period) was 12-SEP-2014 and EDD (Estimated date of delivery) was 19-JUN-2015. The pregnancy outcome was outcome pending. No adverse effect reported. No treatment was given. None lab diagnostics studies was performed. Additional information has been requested.
Pt has seizure after each of three MMR, 7/97,7/01,8/01.
Pt is an International student from China.  Was given her 1st of 2 reguired doses of MMR on 09/14/09 subQ in her left arm.  A mantoux test was also given in her right forearm on this day.  She returned to the clinic to have her mantoux read on 09/16/09 when another RN noted that she had a localized reaction to the MMR.  It was an approximately 2 cm induration around the injection site with some warmth noted.  Pt denied pain at the site.
Pt given vaccine at 1150, started to have facial swelling and feeling of throat closing at 1200. Epi Pen given at 1204 and pt transferred by EMS to hospital
1hr p/vax pt devel inj site rxn w/ redness, swelling & pain & fever;pt went to ER & was treated w/Keflex & APAP w/o relief;4 days post vax the swelling was spreading & pt was nauseated & had a fever of 101.4;seen by MD noted induration
started as severe dizziness and weakness, chest pain was hospitalized once I got to the ER because my heart was not working properly, after many test the found my heart was in heart failure with an output of 35% only, was in hospital for 5 days. Doctors couldn't see what caused such a sudden weakness of the heart, they did cardio path and arteries have zero blockage, they did ECO, and a EP Study. My heart now suffers from PVCs or arrhythmia and they are very irregular and frequent. Was given medicine to help the heart and control the PVCs, and discharged with wearing a safety vest, to follow up with the cardio doctors. Followed up with doctors and they have done an MRI which shows scarring of the heart. The doctor has determined that the diagnosis is myocardiatis. There is no proof this direct relation with the vaccine,  however symptoms started soon after the vaccine in a healthy young man. Now I still have to go to another electrophysiologist to see what he can do to help alleviate the PVCs and continue to take the medication to see of the heart can improve. I could not work for a month, and still cannot resume normal activities because my heart is to weak to sustain it.
Migraine for 2 hours, took tylenol, went away after 30 minutes
Possible adjuvant  administered by itself; administered by itself; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Possible adjuvant  administered by itself) and inappropriate dose of vaccine administered (Verbatim: administered by itself). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 02-MAR-2023 The reporter asked about whether Shingrix adjuvant was sold separately due to there being two extra vials of powder.  The reporter stated she does not feel like adjuvant was given by itself.  This is just being reported as a possible adverse event of (possible) adjuvant being administered by itself to be on the safe side (compliance).  Health care professional feeling like it was not administered by itself (diluent). Health care professional does not feel like an adverse event  occurred. This was being reported at the guidance of my manager to avoid non-compliance. The reporter did not consent to follow-up.  The reporter stated patient does not feel like adjuvant was given by itself which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. This case had been linked with US2023AMR034657, reported by the same reporter different patient.; Sender's Comments:  US-GSK-US2023AMR034657:Same reporter. Patient 2
One swollen, hard, painful lymph node at 12:45 PM 06/19/2012. Cluster of at least 3 swollen, hard, painful lymph nodes upon awakening at 11:00 AM 06/20/2012.
Pt came to ER with difficulty breathing and respiratory problems.  Onset was just prior to arrival.
Approx 4 months post vax (3rd dose) 13MAR92 pt was hospitalized for fever, high WBC & vomiting; dx was H. flu meningitis type B; tx Cefotaxim; pt is improving;